Gadobutrol

Gadobutrol is a contrast agent used in magnetic resonance imaging (MRI) scans. It is a gadolinium-based contrast agent that is injected into a patient’s veins to improve the visibility of organs, blood vessels, and other structures in the body. Gadobutrol can also be used to diagnose and monitor a variety of medical conditions, such as cancer, heart conditions, and brain disorders. It is known to be safe and well tolerated by most patients.\

Gadobutrol is a gadolinium-based contrast agent (GBCA) used in diagnostic imaging examinations called Magnetic Resonance Imaging (MRI).

Function in MRI:

  • An MRI scan on its own provides detailed anatomical images of organs and tissues.
  • Gadobutrol is injected into a vein shortly before the MRI scan.
  • As a contrast agent, it alters how certain tissues appear in the scan.
  • By affecting the relaxation properties of water molecules in tissues, gadobutrol enhances the contrast between healthy and abnormal tissues, allowing for better visualization of specific areas.

Applications in MRI:

  • Gadobutrol is helpful in examining various parts of the body, including:
    • Central nervous system (CNS): It can help identify lesions, tumors, and abnormalities in the brain and spine by highlighting areas with disrupted blood-brain barrier (BBB) or abnormal blood flow.
    • Blood vessels: It can be used in magnetic resonance angiography (MRA) to assess blood flow and detect abnormalities in vessels, aiding in the diagnosis of stroke, tumor blood supply, and blockages.
    • Breast tissue: In some cases, gadobutrol-enhanced MRI can improve the detection of breast cancer.
    • Other organs: It may also be used for imaging other organs and tissues depending on the specific diagnostic needs.

Important Considerations:

  • Gadobutrol is generally well-tolerated, but there can be side effects like nausea, headache, dizziness, and injection site reactions.
  • More serious side effects, like allergic reactions, are uncommon but possible.
  • People with impaired kidney function may not be suitable candidates for gadobutrol due to potential for gadolinium accumulation in the body. There is ongoing research about the long-term effects of gadolinium in some patients.
  • There are rare concerns about a possible link between GBCAs and a condition called nephrogenic systemic fibrosis (NSF). However, the risk is extremely low for most patients with normal kidney function.

Overall, gadobutrol is a valuable tool for enhancing MRI scans and improving diagnostic accuracy. However, it's important to discuss the potential benefits and risks with your doctor before undergoing an MRI with gadobutrol, especially if you have kidney problems

Anatomical Therapeutic Chemical Classification
V - Various
V08 Contrast media
V08C - Magnetic resonance imaging contrast media
V08CA Paramagnetic contrast media
External Links